» Articles » PMID: 14685775

1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): II. Role of O6-alkylguanine-DNA Alkyltransferase in Cytotoxicity

Overview
Specialty Oncology
Date 2003 Dec 20
PMID 14685775
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: VNP40101M (1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine) is a sulfonylhydrazine prodrug that possesses broad spectrum antitumor efficacy in murine models. VNP40101M activation generates chloroethylating species that alkylate DNA at the O(6)-position of guanine, and a carbamoylating agent, methyl isocyanate, which inhibits O(6)-alkylguanine-DNA alkyltransferase (AGT) in model systems. We determined whether expression of AGT in Chinese hamster ovary (CHO) cells decreased sensitivity to VNP40101M and explored the mechanism of VNP40101M cytotoxicity by employing analogs of VNP40101M that generate reactive intermediates with either carbamoylating or chloroethylating activity.

Methods: AGT was overexpressed in CHO cells by transfection with an expression vector containing the human AGT gene. Cell lines expressing AGT were employed in clonogenic assays to determine the cytotoxicity of VNP40101M and its analogs.

Results: VNP40101M was more active against AGT-expressing CHO cells than 90CE (1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine), a chloroethylating generator devoid of carbamoylating activity. Furthermore, the greater the degree of AGT expression the more resistance to VNP40101M cytotoxicity. Combination chemotherapy experiments support the conclusions that methyl isocyanate and the chloroethylating species generated from the activation of VNP40101M function synergistically to kill cells.

Conclusions: The findings support the concept that alkylation of the O(6)-position of guanine residues in DNA is the predominant lesion created by VNP40101M, and that methyl isocyanate resulting from the base-catalyzed activation of VNP40101M inhibits AGT and presumably other enzymes involved in DNA repair, thereby enhancing the yield of the DNA G-C interstrand crosslinks responsible for the antitumor activity of this agent.

Citing Articles

Hypoxia-targeted drug delivery.

Sharma A, Arambula J, Koo S, Kumar R, Singh H, Sessler J Chem Soc Rev. 2018; 48(3):771-813.

PMID: 30575832 PMC: 6361706. DOI: 10.1039/c8cs00304a.


pH-dependent general base catalyzed activation rather than isocyanate liberation may explain the superior anticancer efficacy of laromustine compared to related 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine prodrugs.

Penketh P, Finch R, Sauro R, Baumann R, Ratner E, Shyam K Chem Biol Drug Des. 2017; 91(1):62-74.

PMID: 28636806 PMC: 5740024. DOI: 10.1111/cbdd.13057.


Influence of the Expression Level of O6-Alkylguanine-DNA Alkyltransferase on the Formation of DNA Interstrand Crosslinks Induced by Chloroethylnitrosoureas in Cells: A Quantitation Using High-Performance Liquid Chromatography-Mass Spectrometry.

Li L, Li S, Sun G, Peng R, Zhao L, Zhong R PLoS One. 2015; 10(3):e0121225.

PMID: 25799182 PMC: 4370500. DOI: 10.1371/journal.pone.0121225.


Carbamoylating activity associated with the activation of the antitumor agent laromustine inhibits angiogenesis by inducing ASK1-dependent endothelial cell death.

Ji W, Yang M, Praggastis A, Li Y, Zhou H, He Y PLoS One. 2014; 9(7):e103224.

PMID: 25068797 PMC: 4113355. DOI: 10.1371/journal.pone.0103224.


Hypoxia-selective O6-alkylguanine-DNA alkyltransferase inhibitors: design, synthesis, and evaluation of 6-(benzyloxy)-2-(aryldiazenyl)-9H-purines as prodrugs of O6-benzylguanine.

Zhu R, Baumann R, Penketh P, Shyam K, Sartorelli A J Med Chem. 2013; 56(3):1355-9.

PMID: 23311288 PMC: 3722860. DOI: 10.1021/jm301804p.